135 related articles for article (PubMed ID: 19567353)
1. Fluoroquinolone treatment of chronic bacterial prostatitis: a prospective cohort study.
Panagopoulos P; Antoniadou A; Kanellakopoulou K; Tsiodras S; Katsarolis I; Papadopoulos A; Galani L; Giamarellou H
J Chemother; 2009 Jun; 21(3):317-21. PubMed ID: 19567353
[TBL] [Abstract][Full Text] [Related]
2. Management of bacterial prostatitis: what's new?
Naber KG
BJU Int; 2008 Mar; 101 Suppl 3():7-10. PubMed ID: 18307679
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model.
Lee YS; Han CH; Kang SH; Lee SJ; Kim SW; Shin OR; Sim YC; Lee SJ; Cho YH
Int J Urol; 2005 Apr; 12(4):383-9. PubMed ID: 15948727
[TBL] [Abstract][Full Text] [Related]
4. Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
Giannarini G; Mogorovich A; Valent F; Morelli G; De Maria M; Manassero F; Barbone F; Selli C
J Chemother; 2007 Jun; 19(3):304-8. PubMed ID: 17594926
[TBL] [Abstract][Full Text] [Related]
5. Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis.
Weidner W; Ludwig M; Brähler E; Schiefer HG
Drugs; 1999; 58 Suppl 2():103-6. PubMed ID: 10553717
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical symptoms scored according to the National Institutes of Health chronic prostatitis symptoms index and assessment of antimicrobial treatment in patients with chronic prostatitis syndrome.
Skerk V; Roglić S; Cajić V; Markotić A; Radonić A; Skerk V; Granić J; Zidovec-Lepej S; Parazajder J; Begovac J
J Chemother; 2009 Apr; 21(2):181-7. PubMed ID: 19423471
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study.
Bundrick W; Heron SP; Ray P; Schiff WM; Tennenberg AM; Wiesinger BA; Wright PA; Wu SC; Zadeikis N; Kahn JB
Urology; 2003 Sep; 62(3):537-41. PubMed ID: 12946763
[TBL] [Abstract][Full Text] [Related]
8. Comparison of results after fluoroquinolones and combination therapies in type IIIA chronic prostatitis.
Altintas R; Oguz F; Beytur A; Ediz C; Gunes A; Ozer A
Actas Urol Esp; 2013; 37(10):619-24. PubMed ID: 23768504
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and antimicrobial effects of garlic and synergistic effect between garlic and ciprofloxacin in a chronic bacterial prostatitis rat model.
Sohn DW; Han CH; Jung YS; Kim SI; Kim SW; Cho YH
Int J Antimicrob Agents; 2009 Sep; 34(3):215-9. PubMed ID: 19375896
[TBL] [Abstract][Full Text] [Related]
10. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?
Nickel JC; Shoskes D; Wang Y; Alexander RB; Fowler JE; Zeitlin S; O'Leary MP; Pontari MA; Schaeffer AJ; Landis JR; Nyberg L; Kusek JW; Propert KJ
J Urol; 2006 Jul; 176(1):119-24. PubMed ID: 16753385
[TBL] [Abstract][Full Text] [Related]
11. Prostatitis: US perspective.
Schaeffer AJ
Int J Antimicrob Agents; 1999 May; 11(3-4):205-11; discussion 213-6. PubMed ID: 10394972
[TBL] [Abstract][Full Text] [Related]
12. [Classification, diagnosis and treatment of prostatitis syndrome].
Krhen I; Skerk V; Schönwald S; Mareković Z
Lijec Vjesn; 2002; 124(3-4):89-98. PubMed ID: 18956827
[TBL] [Abstract][Full Text] [Related]
13. Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis.
Naber KG;
Int J Antimicrob Agents; 2002 Jul; 20(1):18-27. PubMed ID: 12127707
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
Ekici S; Cengiz M; Turan G; Alış EE
Int Urol Nephrol; 2012 Feb; 44(1):19-27. PubMed ID: 21547465
[TBL] [Abstract][Full Text] [Related]
15. Chronic bacterial prostatitis (NIH type II): diagnosis, therapy and influence on the fertility status.
Wagenlehner FM; Diemer T; Naber KG; Weidner W
Andrologia; 2008 Apr; 40(2):100-4. PubMed ID: 18336459
[TBL] [Abstract][Full Text] [Related]
16. [Re-examination of the criteria for clinical evaluation on bacterial prostatitis--analysis of the data of the clinical study of temafloxacin].
Arakawa S; Kamidono S; Hirose T; Kumamoto Y; Suzuki K; Ito Y; Ban Y; Kawada Y; Kumon H; Ohmori H
Hinyokika Kiyo; 1994 May; 40(5):455-66. PubMed ID: 8023771
[TBL] [Abstract][Full Text] [Related]
17. The rapid development of fluoroquinolone resistance in M. tuberculosis.
Ginsburg AS; Woolwine SC; Hooper N; Benjamin WH; Bishai WR; Dorman SE; Sterling TR
N Engl J Med; 2003 Nov; 349(20):1977-8. PubMed ID: 14614180
[No Abstract] [Full Text] [Related]
18. Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction.
Magri V; Montanari E; Škerk V; Markotić A; Marras E; Restelli A; Naber KG; Perletti G
Asian J Androl; 2011 Nov; 13(6):819-27. PubMed ID: 21765442
[TBL] [Abstract][Full Text] [Related]
19. How I manage bacterial prostatitis.
Lam JC; Lang R; Stokes W
Clin Microbiol Infect; 2023 Jan; 29(1):32-37. PubMed ID: 35709903
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
